Complex controls: The role of alternative promoters in mammalian genomes

Trends in Genetics

Volumn 19, Issue 11, 2003, Pages 640-648

  Landry, Josette Renée ^a   Mager, Dixie L ^a   Wilhelm, Brian T ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; ISOPROTEIN; MESSENGER RNA; PROTEIN P53;

5' UNTRANSLATED REGION; EXON; EXPRESSED SEQUENCE TAG; GENE FUNCTION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; HUMAN GENOME; MAMMALIAN GENETICS; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA TRANSLATION; TUMOR SUPPRESSOR GENE;

MAMMALIA;

EID: 0242317345     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2003.09.014     Document Type: Review

References (62)

1. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921.
2. Waterston R.H., et al. Initial sequencing and comparative analysis of the mouse genome. Nature. 420:2002;520-562.
3. Modrek B., et al. Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res. 29:2001;2850-2859.
4. Zavolan M., et al. Splice variation in mouse full-length cDNAs identified by mapping to the mouse genome. Genome Res. 12:2002;1377-1385.
5. Trinklein N.D., et al. Identification and functional analysis of human transcriptional promoters. Genome Res. 13:2003;308-312.
6. Tatusova T.A., Madden T.L. BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol. Lett. 174:1999;247-250.
7. Kamat A., et al. Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol. Metab. 13:2002;122-128.
8. Bonham K., et al. An alternative human SRC promoter and its regulation by hepatic nuclear factor-1alpha. J. Biol. Chem. 275:2000;37604-37611.
9. Saleh A., et al. Identification of a novel Ly49 promoter that is active in bone marrow and fetal thymus. J. Immunol. 168:2002;5163-5169.
10. Landry J.-R., et al. The Opitz syndrome gene Mid1 is transcribed from a human endogenous retroviral promoter. Mol. Biol. Evol. 19:2002;1934-1942.
11. Medstrand P., et al. Long terminal repeats are used as alternative promoters for the endothelin B receptor and apolipoprotein C-I genes in humans. J. Biol. Chem. 276:2001;1896-1903.
12. Landry J.-R., Mager D.L. Functional analysis of the endogenous retroviral promoter of the human endothelin B receptor gene. J. Virol. 77:2003;7459-7466.
13. Phelps D.E., et al. Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis. Mol. Cell. Biol. 18:1998;2334-2343.
14. Wang Y., et al. RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 96:1999;12150-12155.
15. Larsen L.K., et al. Genomic organization of the mouse peroxisome proliferator-activated receptor beta/delta gene: alternative promoter usage and splicing yield transcripts exhibiting differential translational efficiency. Biochem. J. 366:2002;767-775.
16. Golovine K., et al. Three different promoters control expression of the aromatase cytochrome P450 gene (Cyp19) in mouse gonads and testis. Biol. Reprod. 68:2003;978-984.
17. Landry J.-R., Mager D.L. Widely spaced alternative promoters, conserved between human and rodent, control expression of the Opitz Syndrome gene MID1. Genomics. 80:2002;499-508.
18. Minegishi N., et al. Alternative promoters regulate transcription of the mouse GATA-2 gene. J. Biol. Chem. 273:1998;3625-3634.
19. Pan X., et al. Identification of human GATA-2 gene distal IS exon and its expression in hematopoietic stem cell fractions. J Biochem. (Tokyo). 127:2000;105-112.
20. Lee M.A., et al. Tissue- and development-specific expression of mutliple alternatively spliced transcripts of rat neuronal nitric oxide synthase. J. Clin. Invest. 100:1997;1507-1512.
21. Aizencang G.I., et al. Uroporphyrinogen III synthase: an alternative promoter controls erythroid-specific expression in the murine gene. J. Biol. Chem. 275:2000;2295-2304.
22. Aizencang G.I., et al. Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression. Genomics. 70:2000;223-231.
23. Hu Z., et al. Multiple and tissue-specific promoter control of gonadal and non-gonadal prolactin receptor gene expression. J. Biol. Chem. 271:1996;10242-10246.
24. Hu Z.-Z., et al. Complex 5′ genomic structure of the human prolactin receptor: multiple alternative exons 1 and promoter utilization. Endocrinology. 143:2002;2139-2142.
25. Kamat A., et al. A 500-bp region, ∼40 kb upstream of the human CYP19 (aromatase) gene, mediates placenta-specific expression in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 96:1999;4575-4580.
26. van de Lagemaat, L.N. et al. Transposable elements promote regulatory variation and diversification of genes with specialized functions in mammals. Trends Genet. (in press).
27. Kubota A., et al. Diversity of NK cell receptor repertoire in adult and neonatal mice. J. Immunol. 163:1999;212-216.
28. Wilhelm B.T., et al. Comparative analysis of the promoter regions and transcriptional start sites of mouse Ly49 genes. Immunogenetics. 53:2001;215-224.
29. Wang Y., et al. A novel, testis-specific mRNA transcript encoding an NH2-terminal truncated nitric-oxide synthase. J. Biol. Chem. 272:1997;11392-11401.
30. Pozniak C.D., et al. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science. 289:2000;304-306.
31. Zaika A.I., et al. deltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J. Exp. Med. 196:2002;765-780.
32. Nakagawa T., et al. Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. Mol. Cell. Biol. 22:2002;2575-2585.
33. Fillippovich I., et al. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. Oncogene. 20:2001;514-522.
34. Yang A., et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transcactivating, death-inducing, and dominant-negative activities. Mol. Cell. 2:1998;305-316.
35. Nylander K., et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J. Pathol. 198:2002;417-427.
36. Yang A., et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 398:1999;714-718.
37. Henriksen M.A., et al. Negative regulation of STAT92E by an N-terminally truncated STAT protein derived from an alternative promoter site. Genes Dev. 16:2002;2379-2389.
38. Chen T., et al. A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. J. Biol. Chem. 277:2002;38746-38754.
39. Wu Q., Maniatis T. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell. 97:1999;779-790.
40. Tasic B., et al. Promoter choice determines splice site selection in protocadherin alpha and gamma pre-mRNA splicing. Mol. Cell. 10:2002;21-33.
41. Wang X., et al. Molecular mechanisms governing Pcdh-gamma gene expression: Evidence for a multiple promoter and cis-alternative splicing model. Genes Dev. 16:2002;1890-1905.
42. Quelle D.E., et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 83:1995;993-1000.
43. Robertson K.D., Jones P.A. Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus. Oncogene. 18:1999;3810-3820.
44. Sherr C.J. The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell Biol. 2:2001;731-737.
45. Waf1/Cip1 is induced by the p53 family. Oncogene. 21:2002;1285-1294.
46. Lynch M., Conery J.S. The evolutionary fate and consequences of duplicate genes. Science. 290:2000;1151-1155.
47. Rosenberg N., Jolicoeur P. Retroviral pathogenesis. Coffin J.M., et al. Retroviruses. 1997;475-586 Cold Spring Harbor Press.
48. Jordan I.K., et al. Origin of a substantial fraction of human regulatory sequences from transposable elements. Trends Genet. 19:2003;68-72.
49. Pecci A., et al. Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene. J. Biol. Chem. 276:2001;21062-21069.
50. Logette E., et al. The human caspase-2 gene: alternative promoters, pre-mRNA splicing and AUG usage direct isoform-specific expression. Oncogene. 22:2003;935-946.
51. Cramer P., et al. Coupling of transcription with alternative splicing: RNA Pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol. Cell. 4:1999;251-258.
52. Nogues G., et al. Transcriptional activators differ in their abilities to control alternative splicing. J. Biol. Chem. 277:2002;43110-43114.
53. Bar I., et al. The gene encoding disabled-1 (DAB1), the intracellular adaptor of the Reelin pathway, reveals unusual complexity in human and mouse. J. Biol. Chem. 278:2003;5802-5812.
54. Ventura A., et al. The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. J. Biol. Chem. 277:2002;22370-22376.
55. Luzi L., et al. Evolution of the Shc functions from nematode to human. Curr. Opin. Genet. Dev. 10:2000;668-674.
56. Chuvpilo S., et al. Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity. 16:2002;881-895.
57. Fajas L., et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J. Biol. Chem. 272:1997;18779-18789.
58. Sundvold H., Lien S. Identification of a novel peroxisome proliferator-activated receptor (PPAR) gamma promoter in man and transactivation by the nuclear receptor RORalpha1. Biochem. Biophys. Res. Commun. 287:2001;383-390.
59. Boj S.F., et al. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc. Natl. Acad. Sci. U. S. A. 98:2001;14481-14486.
60. Nakhei H., et al. An alternative splice variant of the tissue specific transcription factor HNF4alpha predominates in undifferentiated murine cell types. Nucleic Acids Res. 26:1998;497-504.
61. Pan Y.-X., et al. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc. Natl. Acad. Sci. U. S. A. 98:2001;14084-14089.
62. Kogerman P., et al. Alternative first exons of PTCH1 are differentially regulated in vivo and might confer different functions to the PTCH1 protein. Oncogene. 21:2002;6007-6016.